Oral sildenafil therapy improves health-related quality of life and functional status in pulmonary arterial hypertension

International Journal of Cardiology

Volumn 119, Issue 3, 2007, Pages 400-402

  Wong, Raymond Ching Chiew ^a   Koh, Geok Mui ^a   Choong, Poh Hoon ^a   Yip, Wei Luen James ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Functional class; Health related quality of life; Oral sildenafil; Pulmonary arterial hypertension

Indexed keywords

CYCLIC GMP; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; EMOTION; ENERGY; EXERCISE; FUNCTIONAL ASSESSMENT; GENERAL HEALTH QUESTIONNAIRE; HEALTH STATUS; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; SHORT FORM 36; TREATMENT OUTCOME; WALKING; WORLD HEALTH ORGANIZATION;

ADULT; CROSS-SECTIONAL STUDIES; EXERCISE TOLERANCE; HEALTH STATUS; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; QUALITY OF LIFE; SULFONES;

EID: 34250309261     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.07.170     Document Type: Article

References (15)

1. Brenot F. Primary pulmonary hypertension. Case series from France. Chest 105 (1994) 33S-36S
2. Oakley C.W. Primary pulmonary hypertension. Case series from the United Kingdom. Chest 105 (1994) 29S-32S
3. D'Alonzo G.E., Barst R.J., Ayres S.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115 (1991) 343-349
4. Shafazand S., Goldstein M.K., Doyle R.L., Hlatky M.A., and Gould M.K. Health-related quality of life in patients with pulmonary arterial hypertension. Chest 126 (2004) 1452-1459
5. Ware J.E., and Kosinski M. Interpreting SF-36 summary health measures: a response. Qual Life Res 10 (2001) 405-413 [discussion 415-20]
6. Hatle L., Angelsen B.A., and Tromsdal A. Non-invasive estimation of pulmonary artery systolic pressure with Doppler ultrasound. Br Heart J 45 (1981) 157-165
7. Zoghbi W.A., and Quinones M.A. Determination of cardiac output by Doppler echocardiography: a critical appraisal. Herz 11 (1986) 258-268
8. Garcia Hernandez F.J., Ocana Medina C., Mateos Romero L., et al. Combined treatment with intravenous prostacyclin and sildenafil in patients with pulmonary hypertension: report of 4 cases. Med Clin (Barc) 122 (2004) 64-66
9. Wilkens H., Guth A., Konig J., et al. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 104 (2001) 1218-1222
10. Ghofrani H.A., Wiedemann R., Rose F., et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 136 (2002) 515-522
11. Galie N., Ghofrani H.A., Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
12. Sastry B.K., Narasimhan C., Reddy N.K., and Raju B.S. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol 43 (2004) 1149-1153
13. Michelakis E., Tymchak W., Lien D., Webster L., Hashimoto K., and Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 105 (2002) 2398-2403
14. Kothari S.S., and Duggal B. Chronic oral sildenafil therapy in severe pulmonary artery hypertension. Indian Heart J 54 (2002) 404-409
15. Taichman D.B., Shin J., Hud L., et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res 6 (2005) 92